Filter by: patients
Home > Community Treatment Reports and Side Effects > MS Phase 2 Study ONO-4641 Treatment Report
What is MS Phase 2 Study ONO-4641?

NCT01081782 is a a double-blind, placebo-controlled study of the safety and efficacy of ONO-4641 in patients with relapsing-remitting multiple sclerosis. Other study names is ONO-4641POU006.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
MS (Multiple Sclerosis) 1 1 Efficacy_none

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 1

Reported Stop Reasons

Why Patients Stopped Using MS Phase 2 Study ONO-4641 (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 1   Did not seem to work: 100%
Doctor's advice 1   Doctor's advice: 100%

See all 1 patient who’ve stopped using MS Phase 2 Study ONO-4641

Reported Duration See details about how long patients take this treatment ▼

Stopped Using MS Phase 2 Study ONO-4641

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of MS Phase 2 Study ONO-4641

Always
 1 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of MS Phase 2 Study ONO-4641

Very
 0 0%
Somewhat
 0 0%
A little
 0 0%
Not at all
 1 100%

Cost

Paid out of pocket

Cost of MS Phase 2 Study ONO-4641

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 0 0%

Report created on May 26, 2012.